{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:42:08Z","timestamp":1787316128593,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.81400990"],"award-info":[{"award-number":["No.81400990"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Guangdong Province of China","award":["No. 2014A030310197"],"award-info":[{"award-number":["No. 2014A030310197"]}]},{"name":"the Science and Technology Plan of Guangdong Province of China","award":["No. 2016A020215113"],"award-info":[{"award-number":["No. 2016A020215113"]}]},{"name":"the President Funding of Nanfang Hospital, Southern Medical University","award":["No. 2016B017"],"award-info":[{"award-number":["No. 2016B017"]}]},{"name":"Hong Kong RGC GRF Grant","award":["Ref No.17102915"],"award-info":[{"award-number":["Ref No.17102915"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1267-5","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T14:06:08Z","timestamp":1535033168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke"],"prefix":"10.1186","volume":"15","author":[{"given":"Miaodan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfei","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoqin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nailiang","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"1267_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/bmb\/ldp028","volume":"92","author":"CD Mathers","year":"2009","unstructured":"Mathers CD, Boerma T, Ma FD. Global and regional causes of death. Br Med Bull. 2009;92:7\u201332.","journal-title":"Br Med Bull"},{"key":"1267_CR2","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"Group TNI of ND and S rt-PSS","year":"1995","unstructured":"Group TNI of ND and S rt-PSS. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581\u20137.","journal-title":"N Engl J Med"},{"key":"1267_CR3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.110.974675","volume":"123","author":"GC Fonarow","year":"2011","unstructured":"Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123:750\u20138.","journal-title":"Circulation"},{"key":"1267_CR4","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1161\/01.STR.0000143219.16695.af","volume":"35","author":"X Wang","year":"2004","unstructured":"Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35:2726\u201330.","journal-title":"Stroke"},{"key":"1267_CR5","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.2507","volume":"17","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Eckle T. Ischemia and reperfusion--from mechanism to translation. Nat Med. 2011;17:1391\u2013401.","journal-title":"Nat Med"},{"key":"1267_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796\u2013808.","journal-title":"Nat Med"},{"key":"1267_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1594","volume":"5","author":"MT Lotze","year":"2005","unstructured":"Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5:331\u201342.","journal-title":"Nat Rev Immunol"},{"key":"1267_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1586\/1744666X.2014.909730","volume":"10","author":"B Lu","year":"2014","unstructured":"Lu B, Wang C, Wang M, Li W, Chen F, Tracey KJ, et al. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol. 2014;10:713\u201327.","journal-title":"Expert Rev Clin Immunol"},{"key":"1267_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1523\/JNEUROSCI.2439-14.2015","volume":"35","author":"A Liesz","year":"2015","unstructured":"Liesz A, Dalpke A, Mracsko E, Antoine DJ, Roth S, Zhou W, et al. DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci. 2015;35:583\u201398.","journal-title":"J Neurosci"},{"key":"1267_CR10","doi-asserted-by":"publisher","first-page":"24073","DOI":"10.1038\/srep24073","volume":"6","author":"XX Liu","year":"2016","unstructured":"Liu XX, Wang C, Huang SF, Chen Q, Hu YF, Zhou L, et al. Regnase-1 in microglia negatively regulates high mobility group box 1-mediated inflammation and neuronal injury. Sci Rep. 2016;6:24073.","journal-title":"Sci Rep"},{"key":"1267_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.shk.0000209540.99176.72","volume":"25","author":"RS Goldstein","year":"2006","unstructured":"Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock. 2006;25:571\u20134.","journal-title":"Shock"},{"key":"1267_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","volume":"28","author":"GP Sims","year":"2010","unstructured":"Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol. 2010;28:367\u201388.","journal-title":"Annu Rev Immunol"},{"key":"1267_CR13","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1096\/fj.07-8770com","volume":"21","author":"K Liu","year":"2007","unstructured":"Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 2007;21:3904\u201316.","journal-title":"FASEB J"},{"key":"1267_CR14","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1161\/STROKEAHA.110.598334","volume":"42","author":"J Zhang","year":"2011","unstructured":"Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Maruo T, et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke. 2011;42:1420\u20138.","journal-title":"Stroke"},{"key":"1267_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neulet.2012.07.040","volume":"525","author":"ID Kim","year":"2012","unstructured":"Kim ID, Shin JH, Lee HK, Jin YC, Lee JK. Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain. Neurosci Lett. 2012;525:179\u201383.","journal-title":"Neurosci Lett"},{"key":"1267_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1471-4159.2011.07542.x","volume":"120","author":"Y Gu","year":"2012","unstructured":"Gu Y, Zheng G, Xu M, Li Y, Chen X, Zhu W, et al. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem. 2012;120:147\u201356.","journal-title":"J Neurochem"},{"key":"1267_CR17","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","volume":"160","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, Group NCRGW. Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol. 2010;160:1577\u20139.","journal-title":"Br J Pharmacol"},{"key":"1267_CR18","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1161\/STROKEAHA.108.545483","volume":"40","author":"W Liu","year":"2009","unstructured":"Liu W, Hendren J, Qin XJ, Liu KJ. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia. Stroke. 2009;40:2526\u201331.","journal-title":"Stroke"},{"key":"1267_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5607\/en.2013.22.4.301","volume":"22","author":"ID Kim","year":"2013","unstructured":"Kim ID, Lee JK. HMGB1-binding heptamer confers anti-inflammatory effects in primary microglia culture. Exp Neurobiol. 2013;22:301\u20137.","journal-title":"Exp Neurobiol"},{"key":"1267_CR20","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1161\/hs1101.098367","volume":"32","author":"J Chen","year":"2001","unstructured":"Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32:2682\u20138.","journal-title":"Stroke"},{"key":"1267_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1602\/neurorx.2.3.396","volume":"2","author":"ST Carmichael","year":"2005","unstructured":"Carmichael ST. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx. 2005;2:396\u2013409.","journal-title":"NeuroRx"},{"key":"1267_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1592\/phco.19.3.139.30932","volume":"19","author":"SC Fagan","year":"1999","unstructured":"Fagan SC, Garcia JH. Hemorrhagic transformation in focal cerebral ischemia: influence of time to artery reopening and tissue plasminogen activator. Pharmacotherapy. 1999;19:139\u201342.","journal-title":"Pharmacotherapy"},{"key":"1267_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-6606-6-28","volume":"6","author":"H Jeong","year":"2013","unstructured":"Jeong H, Ji K, Kim J, Jou I, Joe E. Repair of astrocytes , blood vessels , and myelin in the injured brain: possible roles of blood monocytes. Mol. Brain. 2013;6:1.","journal-title":"Mol. Brain"},{"key":"1267_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clineuro.2018.03.007","volume":"168","author":"D Ozbek","year":"2018","unstructured":"Ozbek D, Ozturk O, Ekinci G, Midi I. Risk of hemorrhage in ischemic stroke and its relationship with cerebral microbleeds. Clin Neurol Neurosurg Elsevier. 2018;168:112\u20137.","journal-title":"Clin Neurol Neurosurg Elsevier"},{"key":"1267_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2119\/molmed.2014.00022","volume":"20","author":"D Antoine","year":"2014","unstructured":"Antoine D, Harris H. A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins. Mol Med. 2014;20:1.","journal-title":"Mol Med"},{"key":"1267_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","volume":"40","author":"R Kang","year":"2014","unstructured":"Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, et al. HMGB1 in health and disease. Mol Aspects Med Elsevier Ltd. 2014;40:1\u2013116.","journal-title":"Mol Aspects Med Elsevier Ltd"},{"key":"1267_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pharmthera.2013.11.001","volume":"141","author":"D Musumeci","year":"2014","unstructured":"Musumeci D, Roviello GN, Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther. 2014;141:347\u201357.","journal-title":"Pharmacol Ther"},{"key":"1267_CR28","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1073\/pnas.1121146109","volume":"109","author":"K Hayakawa","year":"2012","unstructured":"Hayakawa K, Pham LDD, Katusic ZS, Arai K, Lo EH. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc Natl Acad Sci U S A. 2012;109:7505\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1267_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","volume":"34","author":"GC Jickling","year":"2014","unstructured":"Jickling GC, Liu D, Stamova B, Ander BP, Zhan X, Lu A, et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34:185\u201399.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1267_CR30","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nm926","volume":"9","author":"X Wang","year":"2003","unstructured":"Wang X, Lee SR, Arai K, Lee SR, Tsuji K, Rebeck GW, et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med. 2003;9:1313\u20137.","journal-title":"Nat Med"},{"key":"1267_CR31","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1158\/1078-0432.CCR-12-0221","volume":"18","author":"T Arumugam","year":"2012","unstructured":"Arumugam T, Ramachandran V, Gomez SB, Schmidt AM, Logsdon CD. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis. Clin Cancer Res. 2012;18:4356\u201364.","journal-title":"Clin Cancer Res"},{"key":"1267_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.chembiol.2007.03.007","volume":"14","author":"L Mollica","year":"2007","unstructured":"Mollica L, De Marchis F, Spitaleri A, Dallacosta C, Pennacchini D, Zamai M, et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol. 2007;14:431\u201341.","journal-title":"Chem Biol"},{"key":"1267_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neulet.2015.03.012","volume":"593","author":"ID Kim","year":"2015","unstructured":"Kim ID, Luo L, Lee HB, Lee HK, Lee JK. HMGB1-binding heptamer suppresses the synergistic effect of HMGB1 and LPS by interacting directly with HMGB1. Neurosci Lett. 2015;593:40\u20134.","journal-title":"Neurosci Lett"},{"key":"1267_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neuroscience.2017.07.052","volume":"360","author":"X Shi","year":"2017","unstructured":"Shi X, Li M, Huang K, Zhou S, Hu Y, Pan S, et al. HMGB1 binding heptamer peptide improves survival and ameliorates brain injury in rats after cardiac arrest and cardiopulmonary resuscitation. Neurosci IBRO. 2017;360:128\u201338.","journal-title":"Neurosci IBRO"},{"key":"1267_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/ana.20199","volume":"56","author":"LL Latour","year":"2004","unstructured":"Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol. 2004;56:468\u201377.","journal-title":"Ann Neurol"},{"key":"1267_CR36","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1161\/STROKEAHA.114.005249","volume":"45","author":"R Leigh","year":"2014","unstructured":"Leigh R, Jen SS, Hillis AE, Krakauer JW, Barker PB, Stir, et al. Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator. Stroke. 2014;45:2030\u20135.","journal-title":"Stroke"},{"key":"1267_CR37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1212\/WNL.0000000000002862","volume":"87","author":"R Leigh","year":"2016","unstructured":"Leigh R, Christensen S, Campbell BC, Marks MP, Albers GW, Lansberg MG, et al. Pretreatment blood-brain barrier disruption and post-endovascular intracranial hemorrhage. Neurology. 2016;87:263\u20139.","journal-title":"Neurology"},{"key":"1267_CR38","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1242\/jcs.084392","volume":"124","author":"BD Roussel","year":"2011","unstructured":"Roussel BD, Mysiorek C, Rouhiainen A, Jullienne A, Parcq J, Hommet Y, et al. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator. J Cell Sci. 2011;124:2070\u20136.","journal-title":"J Cell Sci"},{"key":"1267_CR39","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19:1584\u201396.","journal-title":"Nat Med"},{"key":"1267_CR40","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1073\/pnas.98.3.1294","volume":"98","author":"C Iadecola","year":"2001","unstructured":"Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A. 2001;98:1294\u20139.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1267-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1267-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1267-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T19:09:41Z","timestamp":1566500981000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1267-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1267-5","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the committee on Animal Care and Use of Nanfang Hospital, Southern Medical University, and the ethics committee of the Nanfang Hospital, Southern Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"237"}}